CTRI/2020/07/026494Recruiting未知
A PROSPECTIVE,RANDOMISED, DOUBLE BLINDED COMPARATIVE STUDY BETWEEN 0.5% BUPIVACAINE AND 0.5% BUPIVACAINE WITH PENTAZOCINE AS AN ADJUVANT IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR POST OPERATIVE ANALGESIA IN UPPER LIMB SURGERY
MIDNAPORE MEDICAL COLLEGE AND HOSPITA0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Age between 18-60 years
- •2. ASA grade 1 & 2
- •3. Elective upper limb Surgery under supraclavicular brachial plexus block
Exclusion Criteria
- •1. Patients with history of
- •Uncontrolled Diabetes-Mellitus
- •Uncontrolled Hypertension
- •Coagulopathy
- •Liver disease
- •Cardio pulmonary disease
- •Renal insufficiency or failure
- •Musculoskeletal disorder
- •Drug and alcohol abuse
- •2. Pregnant patients
- •3. BMI more than 30
- •4. Allergy to bupivacaine or pentazocine
- •5. Conversion to general anesthesia
- •7. Brachial plexus block failure
- •8. Difficult airway
- •9. Surgeries with intraoperative time more than 2 hours.
- •10. Patient who received analgesic in the pre operative phase (within effective time range of that particular drug)
- •11. Unwilling to participate
- •12. Serology positive (HIV1&2,Hbs ag,Anti HCV), & immunocompromised patients
Investigators
Similar Trials
Completed
Not Applicable
A RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, COMPARATIVE, MULTICENTER STUDY TO ASSESS THE INCIDENCE OF HEMOLYSIS, SAFETY, AND EFFICACY OF TAFENOQUINE (SB-252263, WR238605) VERSUS PRIMAQUINE IN THE TREATMENT OF SUBJECTS WITH PLASMODIUM VIVAX MALARIA-B51 Plasmodium vivax malariaPlasmodium vivax malariaB51PER-048-14GlaxoSmithKline,100
Active, not recruiting
Phase 1
PROSPECTIVE, RANDOMIZED, DUOBLE BLIND COMPARISON BETWEEN SUBARACNOID ANAESTHESIA AND SUBARACNOID ANAESTHESIA WITH BLOCK OF FEMORAL NERVE IN PATIENTS UNDERGOING SURGERY FOR ANTERIOR LIGAMENT REPAIR. - NDPATIENTS UNDERGOING SURGERY FOR CRUSADER ANTERIOR LIGAMENTMedDRA version: 9.1Level: SOCClassification code 10028395Term: Musculoskeletal and connective tissue disordersEUCTR2007-000421-21-ITOSPEDALE S. RAFFAELE40
Active, not recruiting
Phase 1
A RANDOMIZED, COMPARATIVE, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTER, MONOTHERAPY, STUDY OF PREGABALIN (LYRICA) AND LAMOTRIGINE (LAMICTAL) IN PATIENTS WITH NEWLY DIAGNOSED PARTIAL SEIZURES - N/AEpilepsyEUCTR2005-004023-19-GBPfizer Ltd, Ramsgate Rd, Sandwich, Kent, United Kingdom660
Active, not recruiting
Not Applicable
A RANDOMIZED, COMPARATIVE, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTER, MONOTHERAPY, STUDY OF PREGABALIN (LYRICA) AND LAMOTRIGINE (LAMICTAL) IN PATIENTS WITH NEWLY DIAGNOSED PARTIAL SEIZURESPatients with newly diagnosed partial seizures (with or without secondary generalization)MedDRA version: 9.1Level: LLTClassification code 10061334Term: Partial seizuresEpilepsyEUCTR2005-004023-19-DEPfizer Pharma GmbH626
Active, not recruiting
Not Applicable
A RANDOMIZED, COMPARATIVE, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTER, MONOTHERAPY, STUDY OF PREGABALIN LYRICA AND LAMOTRIGINE LAMICTAL IN PATIENTS WITH NEWLY DIAGNOSED PARTIAL SEIZURES - NDmonotherapy in patients newly diagnosed with partial seizures with or without secondary generalizationMedDRA version: 8.1Level: LLTClassification code 10061334Term: Partial seizuresEpilepsyEUCTR2005-004023-19-ITPFIZER800